Heron Therapeutics (HRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,367 | -55,283 | -23,348 | -11,814 | -7,346 |
| Depreciation Amortization | 1,151 | 866 | 586 | 282 | 227 |
| Accounts receivable | N/A | N/A | N/A | 110 | 61 |
| Accounts payable and accrued liabilities | 1,285 | -426 | 984 | 467 | -3 |
| Other Working Capital | 5,945 | 2,764 | 1,103 | 1,542 | -267 |
| Other Operating Activity | 7,704 | 11,316 | 3,666 | 1,692 | 1,845 |
| Operating Cash Flow | $-60,282 | $-40,763 | $-17,009 | $-7,721 | $-5,483 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,438 | -1,685 | -972 | -513 | -78 |
| Investing Cash Flow | $-1,438 | $-1,685 | $-972 | $-513 | $-78 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,000 | 24,084 | N/A |
| Common Stock Issued | 62,108 | 60,629 | 50,513 | 15 | 77 |
| Other Financing Activity | 0 | 600 | 0 | 0 | 0 |
| Financing Cash Flow | $62,108 | $61,229 | $53,513 | $24,099 | $77 |
| Beginning Cash Position | 72,287 | 53,506 | 17,974 | 2,109 | 7,593 |
| End Cash Position | 72,675 | 72,287 | 53,506 | 17,974 | 2,109 |
| Net Cash Flow | $388 | $18,781 | $35,532 | $15,865 | $-5,484 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,282 | -40,763 | -17,009 | -7,721 | -5,483 |
| Capital Expenditure | -1,438 | -1,685 | -972 | -513 | -78 |
| Free Cash Flow | -61,720 | -42,448 | -17,981 | -8,234 | -5,561 |